(Q37625814)

21 August 2017

1 reference

title

Current understanding of osteoporosis associated with liver disease (English)

1 reference

21 August 2017

0 references

Inaam A Nakchbandi

1

1 reference

PubMed ID

19881518

21 August 2017

Schalk W van der Merwe

series ordinal

2

1 reference

PubMed ID

19881518

21 August 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Nature Reviews Gastroenterology & Hepatology

21 August 2017

1 reference

21 August 2017

6

1 reference

21 August 2017

11

1 reference

21 August 2017

660-670

1 reference

https://scigraph.springernature.com/pub.10.1038/nrgastro.2009.166

21 August 2017

0 references

cites work

Reduced bone mineral density and altered bone turnover markers in patients with non-cirrhotic chronic hepatitis B or C infection

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Serum osteoprotegerin and RANKL levels in chronic alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Male hypogonadism in cirrhosis and after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Circulating levels of IGF-1 directly regulate bone growth and density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone disorders in chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoporosis and skeletal fractures in chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoporosis in primary biliary cirrhosis: pathogenesis and treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoimmunology--the hidden immune regulation of bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Evaluation and management of osteoporosis in liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

AGA technical review on osteoporosis in hepatic disorders.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone mineral density before and after OLT: long-term follow-up and predictive factors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Collagen type Ialpha1 and vitamin D receptor gene polymorphisms and bone mass in primary biliary cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone disease in primary biliary cirrhosis: independent indicators and rate of progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone metabolism in advanced cholestatic liver disease: analysis by bone histomorphometry

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Early increase of bone resorption in patients with liver cirrhosis secondary to viral hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteodystrophy in patients with chronic hepatitis and liver cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Prolonged-efficacy of bisphosphonate in postmenopausal women with osteoporosis and chronic liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Risk factors for bone loss in chronic active hepatitis and primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoporosis in hemochromatosis: iron excess, gonadal deficiency, or other factors?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

25-Hydroxylation of vitamin D in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Calcitriol for bone loss in patients with primary biliary cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Calcitriol for bone disease in patients with cirrhosis of the liver.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

The association between body mass index and osteoporosis in patients referred for a bone mineral density examination

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Leptin and the regulation of body weight in mammals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Expression of leptin and leptin receptor during the development of liver fibrosis and cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

The severity of liver fibrosis is associated with high leptin levels in chronic hepatitis C

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Inverse relationship between circulating levels of leptin and bone mineral density in chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone mineral density in men with genetic hemochromatosis and HFE gene mutation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone loss in primary biliary cirrhosis: absence of association with severity of liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Gene polymorphisms as predictors of decreased bone mineral density and osteoporosis in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Vitamin D-receptor genotypes as independent genetic predictors of decreased bone mineral density in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Determinants of peak bone mass: clinical and genetic analyses in a young female Canadian cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Association between iron overload and osteoporosis in patients with hereditary hemochromatosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Does iron affect osteoblast function? Studies in vitro and in patients with chronic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Decreased bone density, elevated serum osteoprotegerin, and beta-cross-laps in Wilson disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Hyperbilirubinemia is not a major contributing factor to altered bone mineral density in patients with chronic liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Advances in the management of corticosteroid-induced osteoporosis with bisphosphonates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Safety issues in the management of autoimmune hepatitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Hepatic osteodystrophy in rats results mainly from portasystemic shunting.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Normal growth and development in the absence of hepatic insulin-like growth factor I

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Two years of treatment with recombinant human growth hormone increases bone mineral density in men with idiopathic osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Circulating levels of insulin-like growth factors and their binding proteins in patients with chronic liver disease: lack of correlation with bone mineral density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Mechanisms of sex steroid effects on bone.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Estrogen promotes early osteoblast differentiation and inhibits adipocyte differentiation in mouse bone marrow stromal cell lines that express estrogen receptor (ER) alpha or beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Bone loss and reduced osteoblast function in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Metabolic bone disease in primary biliary cirrhosis at presentation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Low bone turnover state in primary biliary cirrhosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Human Parathyroid Hormone 1–34 Prevents Bone Loss in Experimental Biliary Cirrhosis in Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Ethanol reduces bone formation and may cause osteoporosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoporosis, mineral metabolism, and serum soluble tumor necrosis factor receptor p55 in viral cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Molecular mechanisms of inflammatory bone damage: emerging targets for therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Valid treatment options for osteoporosis and osteopenia in HIV-infected persons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Gut, inflammation and osteoporosis: basic and clinical concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Activated T lymphocytes support osteoclast formation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

The interleukin-17 pathway is involved in human alcoholic liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

High serum osteoprotegerin and low RANKL in primary biliary cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoprotegerin and RANKL in alcoholic liver cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

The RANKL/OPG system and bone mineral density in patients with chronic liver disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Serum osteoprotegerin and its ligand in cirrhotic patients referred for orthotopic liver transplantation: relationship with metabolic bone disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Comparative study of cytotoxicity, tumor necrosis factor, and prostaglandin release after stimulation of rat Kupffer cells, murine Kupffer cells, and murine inflammatory liver macrophages.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Isoform of fibronectin mediates bone loss in patients with primary biliary cirrhosis by suppressing bone formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Gene expression and synthesis of fibronectin isoforms in rat hepatic stellate cells. Comparison with liver parenchymal cells and skin fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Strontium ranelate: a physiological approach for optimizing bone formation and resorption

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Time-evolution and reversibility of strontium-induced osteomalacia in chronic renal failure rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.166

Osteoporosis in primary biliary cirrhosis: effects of 25-hydroxyvitamin D3 treatment.

31 March 2020

1 reference

12 December 2020

Menopausal changes in bone remodeling

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: does ursodeoxycholic acid make a difference?

1 reference

12 December 2020

Bone and joint involvement in genetic hemochromatosis: role of cirrhosis and iron overload

1 reference

12 December 2020

Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women

1 reference

12 December 2020

Fibronectin regulates calvarial osteoblast differentiation.

1 reference

12 December 2020

Factors influencing the development of metabolic bone disease in primary biliary cirrhosis

1 reference

12 December 2020

Tumour necrosis factor, interleukin-1 and interleukin-6 in alcoholic cirrhosis

1 reference

12 December 2020

Bone disease in primary biliary cirrhosis: histologic features and response to 25-hydroxyvitamin D

1 reference

12 December 2020

Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation: a controlled longitudinal study

1 reference

12 December 2020

Ascorbic acid deficiency, iron overload and alcohol abuse underlie the severe osteoporosis in black African patients with hip fractures--a bone histomorphometric study

1 reference

12 December 2020

10.1038/NRGASTRO.2009.166

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

19881518